Placental lesions in pregnant women with SARS-­CoV-­2 infection

1. Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020; 382(8): 727-33. https://dx.doi.org/10.1056/NEJMoa2001017.
2. Coronavirus Disease (COVID-19) Pandemic. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
3. Постановление Правительства РФ от 31 января 2020 г. № 66 «О внесении изменения в перечень заболеваний, представляющих опасность для окружающих». [Decree of the government of the Russian Federation No. 66 of January 31, 2020 "On amendments to the list of diseases that pose a danger to others". (in Russian)]. https://base.garant.ru/73492109/.
4. Беляков А.Н., Рассохин В.В., Ястребова Е.Б. Коронавирусная инфекция COVID-19. Природа вируса, патогенез, клинические проявления. Сообщение 1. ВИЧ-инфекция и иммуносупрессии. 2020; 1: 7-21. [Belyakov N.A., Rassokhin V.V., Yastrebova Е.B. Coronavirus infectious disease COVID-19. Nature of virus, pathogenesis, clinical manifestations. Report 1. HIV infection and immunosuppression. 2020; 1: 7-21. (in Russian)]. https://dx.doi.org/10.22328/2077-9828-2020-12-1-7-21.
5. Pascarella G., Strumia A., Piliego C., Bruno F., Del Buono R., Costa F. et al. COVID-19 diagnosis and management: a comprehensive review. J. Intern. Med. 2020; 288(2): 192-206. https://dx.doi.org/10.1111/joim.13091.
6. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020; 323(13): 1239-42. https://dx.doi.org/10.1001/jama.2020.2648.
7. Yu N., Li W., Kang Q., Xiong Z., Wang S., Lin X. et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect. Dis. 2020; 20(5): 559‐64. https://dx.doi.org/10.1016/S1473-3099(20)30176-6.
8. Припутневич Т.В., Гордеев А.Б., Любасовская Л.А., Шабанова Н.Е. Новый коронавирус SARS-COV-2 и беременность: обзор литературы. Акушерство и гинекология. 2020; 5: 6-12. https://dx.doi.org/10.18565/aig.2020.5.6-12. [Priputnevich T.V., Gordeev A.B., Lyubasovskaya L.A., Shabanova N.E. The novel coronavirus SARS-CoV-2 and pregnancy: literature review. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2020; 5: 6-12. (in Russian)]. https://dx.doi.org/10.18565/aig.2020.5.6-12.
9. Wang Q., Zhang Y., Wu L., Niu S., Song C., Zhang Z. et al. Structural and functional basis of SARSCoV-2 entry by using human ACE2. Cell. 2020; 181(4): 894-904. e9. https://dx.doi.org/10.1016/j.cell.2020.03.045.
10. Di Mascio D., Khalil A., Saccone G., Rizzo G., Buca D., Liberati M. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. MFM. 2020; 2(2): 100107. https://dx.doi.org/10.1016/j.ajogmf.2020.100107.
11. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 2020; 5(4): 536-44. https://dx.doi.org/10.1038/s41564-020-0695-z.
12. Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H. et al. Bats are natural reservoirs of SARS-like. Science. 2005; 310(5748): 676-9. https://dx.doi.org/10.1126/science.1118391.
13. Kupferschmidt K. Emerging diseases. Researchers scramble to understand camel connection toi MERS. Science. 2013; 341(6147): 702. https://dx.doi.org/10.1126/science.341.6147.702.
14. Hoffmann M., Kleine-Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181(2): 271-80. e8. https://dx.doi.org/10.1016/j.cell.2020.02.052.
15. Hamming I., Timens W., Bulthuis M.L.C., Lely A.T., Navis G.J., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004; 203(2): 631-7. https://dx.doi.org/10.1002/path.1570.
16. Wang K., Chen W., Zhou Y.S., Lian J.Q., Zhang Z., Du P. et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. bioRxiv. March 31 2020. Preprint. https://dx.doi.org/10.1101/2020.03.14.988345.
17. Ashary N., Bhide A., Chakraborty P., Colaco S., Mishra A., Chhabria K. et al. Single-Cell RNA-seq identifies cell subsets in human placenta that highly expresses factors driving pathogenesis of SARS-CoV-2. Front. Cell Dev. Biol. 2020; 8: 783. https://dx.doi.org/10.3389/fcell.2020.00783.
18. Constantino F.B., Cury S.S., Nogueira C.R., Carvalho R.F., Justulin L.A. Prediction of non-canonical routes for SARS-CoV-2 infection in human placenta cells. bioRxiv. June 12 2020. https://dx.doi.org/10.1101/2020.06.12.148411.
19. Li M., Chen L., Zhang J., Xiong C., Li X. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One. 2020; 15(4): e0230295. https://dx.doi.org/10.1371/journal.pone.0230295.
20. Pique-Regi R., Romero R., Tarca A.L., Luca F., Xu Y., Alazizi A. et al. Does the human placenta express the canonical cell entry mediators for SARSCoV-2? Elife. 2020 July 14; 9: e58716. https://dx.doi.org/10.7554/eLife.58716.
21. Pringle K.G., Tadros M.A., Callister R.J., Lumbers E.R. The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis? Placenta. 2011; 32(12): 956-62. https://dx.doi.org/10.1016/j.placenta.2011.09.020.
22. Sungnak W., Huang N., Becavin C., Berg M., Queen R., Litvinukova M. et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 2020; 26(5): 681-7. https://dx.doi.org/10.1038/s41591-020-0868-6.
23. Valdes G., Neves L.A., Anton L., Corthorn J., Chacon C., Germain A.M. et al. Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies. Placenta. 2006; 27(2-3): 200-7. https://dx.doi.org/10.1016/j.placenta.2005.02.015.
24. Zheng Q.L., Duan T., Jin L. Single-cell RNA expression profiling of ACE2 and AXL in the human maternal-fetal interface. Reprod. Dev. Med. 2020; 4(1): 7-10. https://dx.doi.org/10.4103/2096-2924.278679.
25. Hecht J.L., Quade B., Deshpande V., Mino-Kenudson M., Ting D.T., Desai N. et al. SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers. Mod. Pathol. 2020; 33(11): 2092-103. https://dx.doi.org/10.1038/s41379-020-0639-4.
26. Bloise E., Zhang J., Nakpu J., Hamada H., Dunk C.E., Li S. et al. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia. Am. J. Obstet. Gynecol. August 25 2020; S0002-9378(20)30884-X. https://dx.doi.org/10.1016/j.ajog.2020.08.055.
27. Vivanti A.J., Vauloup-Fellous C., Prevot S., Zupan V., Suffee C., Cao J.D. et al. Transplacental transmission of SARS-CoV-2 infection. Nat. Commun. 2020; 11(1): 3572. https://dx.doi.org/10.1038/s41467-020-17436-6.
28. Hsu A.L., Guan M., Johannesen E., Stephens A.J., Khaleel N., Kagan N. et al. Placental SARS-CoV-2 in a pregnant woman with mild COVID-19 disease. J. Med. Virol. August 25 2020. https://dx.doi.org/10.1002/jmv.26386.
29. Facchetti F., Bugatti M., Drera E., Tripodo C., Sartori E., Cancila V. et al. SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of placenta. EBioMedicine. 2020; 59: 102951. https://dx.doi.org/10.1016/j.ebiom.2020.102951.
30. Щеголев А.И., Туманова У.Н., Ляпин В.М., Серов В.Н. Синцитиотрофобласт ворсин плаценты в норме и при преэклампсии. Акушерство и гинекология. 2020; 6: 21-8. [Shchegolev A.I., Tumanova U.S., Lyapin V.M., Serov V.N. The syncytiotrophoblast of the placental villi in health and in preeclampsia. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2020; 6: 21-8. (in Russian)]. https://dx.doi.org/10.18565/aig.2020.6.21-28.
31. Delorme-Axford E., Donker R.B., Mouillet J.F., Chu T., Bayer A., Ouyang Y. et al. Human placental trophoblasts confer viral resistance to recipient cells. Proc. Natl. Acad. Sci. USA. 2013; 110(29): 12048-53. https://dx.doi.org/10.1073/pnas.1304718110.
32. Baergen R.N., Heller D.S. Placental pathology in Covid-19 positive mothers: preliminary findings. Pediatr. Dev. Pathol. 2020; 23(3): 177-80. https://dx.doi.org/10.1177/1093526620925569.
33. Gulersen M., Prasannan L., Tam H.T., Metz C.N., Rochelson B., Meirowitz N. et al. Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection. Am. J. Obstet. Gynecol. MFM. 2020; 2(4): 100211. https://dx.doi.org/10.1016/j.ajogmf.2020.100211.
34. Shanes E.D., Mithal L.B., Otero S., Azad H.A., Miller E.S., Goldstein J.A. Placental pathology in COVID-19. Am. J. Clin. Pathol. 2020; 154(1): 23-32. https://dx.doi.org/10.1093/ajcp/aqaa089.
35. Smithgall M.C., Liu-Jarin X., Hamele-Bena D., Cimic A., Mourad M., Debelenko L. et al. Thierd trimester placentas of SARS-CoV-2-positive women: histomorphology, including viral Immunohistochemistry and in situ hybridization. Histopathology. 2020; 77(6): 994-9. https://dx.doi.org/10.1111/HIS.14215.
36. Taglauer E., Benarroch Y., Rop K., Barnett E., Sabharwal V., Yarrington C. et al. Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads. Placenta. 2020; 100: 69-74. https://dx.doi.org/10.1016/j.placenta.2020.08.015.
37. Redline R.W. Classification of placental lesions. Am. J. Obstet. Gynecol. 2015; 213(4, Suppl.): S21-8. https://dx.doi.org/10.1016/j.ajog.2015.05.056.
38. Щеголев А.И. Современная морфологическая классификация повреждений плаценты. Акушерство и гинекология. 2016; 4: 16-23. [Shchegolev A.I. Current morphological classification of damages to the placenta. Akusherstvo i ginekologiya/Obstetrics and gynecology. 2016; 4: 16-23. (in Russian)]. https://dx.doi.org/10.18565/aig.2016.4.16-23.
39. Щеголев А.И., Серов В.Н. Клиническая значимость поражений плаценты. Акушерство и гинекология. 2019; 3: 54-62. [Shchegolev A.I., Serov V.N. Clinical significance of placental lesions. Akusherstvo i ginekologiya/Obstetrics and gynecology. 2019; 3: 54-62. (in Russian)]. https://dx.doi.org/10.18565/aig.2019.3.54-62.
40. Roberts D.J., Post M.D. The placenta in pre-eclampsia and intrauterine growth restriction. J. Clin. Pathol. 2008; 61(12): 1254-60. https://dx.doi.org/10.1136/jcp.2008.055236.
41. Arias F., Victorio A., Cho K., Kraus F. Placental histology and clinical characteristics of patients with preterm premature rupture of membranes. Obstet. Gynecol. 1997; 89(2): 265-71. https://dx.doi.org/10.1016/S0029-7844(96)00451-6.
42. Щеголев А.И., Дубова Е.А., Павлов К.А. Морфология плаценты. М.; 2010. 46 с. [Shchegolev A.I., Dubova E.A., Pavlov K.A. The morphology of the placenta. M.; 2020. 46 p. (in Russian)].
43. Stanek J. Histological features of shallow placental implantation unify early-onset and late-onset preeclampsia. Pediatr. Dev. Pathol. 2019; 22(2): 112-22. https://dx.doi.org/10.1177/1093526618803759.
44. Щеголев А.И., Ляпин В.М., Туманова У.Н., Воднева Д.Н., Шмаков Р.Г. Гистологические изменения плаценты и васкуляризация ее ворсин при ранней и поздней преэклампсии. Архив патологии. 2016; 78(1): 13-8. [Shchegolev A.I., Lyapin V.M., Tumanova U.N., Vodneva D.N., Shmakov R.G. Histological hanges in the placenta and vascularization of its villi in early- and late-onset preeclampsia. Archives of pathology. 2016; 78(1): 13-8. (in Russian)]. https://dx.doi.org/10.17116/patol201678113-18.
45. Ляпин В.М., Туманова У.Н., Щеголев А.И. Синцитиальные узелки в ворсинах плаценты при преэклампсии. Современные проблемы науки и образования. 2015; 4: 499. [Lyapin V.M., Tumanova U.N., Schegolev A.I. Syncytial knots of placental villi at preeclampsia. Sovremennye problemy nauki i obrazovaniya. 2015; 4: 499. (in Russian)].
46. Di Renzo G.C., Giardina I. Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis. Am. J. Obstet. Gynecol. 2020; 223(1): 135. https://dx.doi.org/10.1016/j.ajog.2020.04.017.
47. Mongula J.E., Frenken M.W.E., van Lijnschoten G., Arents N.L.A., de Wit-Zuurendonk L.D., Schimmel-de Kok A.P.A. et al. COVID-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathy. Ultrasound Obstet. Gynecol. 2020; 56(5): 773-6. https://dx.doi.org/10.1002/uog.22189.
48. Stahl K., Bräsen J.H., Hoeper M.M., David S. Direct evidence of SARS-CoV-2 in gut endothelium. Intensive Care Med. 2020; 46(11): 2081-2. https://dx.doi.org/10.1007/s00134-020-06237-6.
49. Soma H., Watanabe Y., Hata T. Chorangiosis and chorangioma in three cohorts of placentas from Nepal, Tibet, and Japan. Reprod. Fertil. Dev. 1995; 7(6): 1533-8. https://dx.doi.org/10.1071/rd9951533.
50. Shchyogolev A.I., Dubova E.A., Pavlov K.A., Lyapin V.M., Kulikova G.V., Shmakov R.G. Morphometric characteristics of terminal villi of the placenta in pre-eclampsia. Bull. Exp. Biol. Med. 2012; 154(1): 92-5. https://dx.doi.org/10.1007/s10517-012-1883-5.
51. Воднева Д.Н., Романова В.В., Дубова Е.А., Павлов К.А., Шмаков Р.Г., Щеголев А.И. Клинико-морфологические особенности ранней и поздней преэклампсии. Акушерство и гинекология. 2014; 2: 35-40. [Vodneva D.N., Romanova V.V., Dubova E.A., Pavlov K.A., Shmakov R.G., Shchegolev A.I. Clinical and morphological features of early and late preeclampsia. Akusherstvo i ginekologiya/Obstetrics and gynecology. 2014; 2: 35-40. (in Russian)].
52. Altshuler G., Russell P. The human placental villitides: a review of chronic intrauterine infection. Curr. Top. Pathol. 1975; 60: 63-112.
53. Ozer E., Cagliyan E., Yuzuguldu R.I., Cevizci M.C., Duman N. Villitis of unknown etiology in the placenta of a pregnancy complicated by COVID-19. Turk. Patoloji Derg. September 8 2020. https://dx.doi.org/10.5146/tjpath.2020.01506.
54. Lv Y., Gu B., Chen Y., Hu S., Ruan T., Xu G. et al. No intrauterine vertical transmission in pregnancy with COVID-19: A case report. J. Infect. Chemother. 2020; 26(12): 1313-5. https://dx.doi.org/10.1016/j.jiac.2020.07.015.
55. Zeng L., Xia S., Yuan W., Yan K., Xiao F., Shao J. et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr. 2020; 174(7): 722-5. https://dx.doi.org/ 10.1001/jamapediatrics.2020.0878.
56. Zeng H., Xu C., Fan J., Tang Y., Deng O., Zhang W. et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA. 2020; 323(18): 1848-9. https://dx.doi.org/10.1001/jama.2020.4861.
57. Patanè L., Morotti D., Giunta M.R., Sigismondi C., Piccoli M.G., Frigerio L. et al. Vertical transmission of COVID-19: SARS-CoV-2 RNA on the fetal side of the placenta in pregnancies with COVID-19 positive mothers and neonates at birth. Am. J. Obstet. Gynecol. MFM. 2020; 2(3): 100145. https://dx.doi.org/10.1016/j.ajogmf.2020.100145.

Received 02.10.2020

Accepted 13.10.2020